Abstract

In contemporary medicine, cancers are recognized as significant concerns warranting attention. Over time, scientific advancements have assisted physicians worldwide in exploring novel approaches. Among these potential solutions are calcium channel blockers (CCBs), which hold considerable importance and find extensive application across various medical conditions. CCBs, classified as dihydropyridines and non-dihydropyridines, have been widely utilized in the management of diverse cancer types. Given the diverse facets of dihydropyridine CCBs, our objective was to comprehensively gather and summarize pertinent data regarding the impact of this medication class on different cancer types.

Keywords: Calcium Channel Blockers (CCBs), neoplasms, cancers, dihydropyridines